BENEV® Partners with LaserAway® to Launch XTherma®: The First High-Frequency RF and Cryogen Combination Therapy Device in the U.S.
Published: 08 Apr 2026
Author: Towards Healthcare
BENEV company is an FDA-registered manufacturer and leading medical aesthetics distribution platform specialising in medical devices, cosmeceuticals, and pharmaceuticals also announced a partnership with LaserAway, the nation's leader in aesthetic dermatology, to expand access to XTherma.
Its main aim is to inspire more vibrant life and create a more beautiful world through products and services that review, restore, and renew. As a global partner, they only seek an alliance with a company that share vision of industry disruption and true value creation.
According to Towards Healthcare, the Therapy devices market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 52.55 billion in 2026 to approximately USD 104.17 billion by 2035, representing a compound annual growth rate (CAGR) of 7.9% from 2026 to 2035. Growth is driven by the increasing prevalence of chronic diseases, with rising healthcare expenditure supported by government and private expenditure, reflecting a shift toward more personal and efficient patient care.
The Science of 'Fire and Ice' Treatment
XTherma device, a system poised to disrupt the non-invasive treatment market. Manufactured by Tentech and exclusively distributed in the U.S. by BENEV, XTherma. It is FDA registered, also known as 10THERMA, it introduce approach to skin tightening and rejuvenation.
The device operates on a dual-modality system, utilize high frequency monopolar RF energy to deliver controlled thermal energy deep into the thermal layer of the skin.
This process creates a gentle heating effect that triggers the body's naturally healing response and stimulates the production of new collagen and elastin, the essential proteins responsible for skin firmness and elasticity.
A Strategic Power Play in Aesthetics
Collaboration between BENEV and LaserAway represents more than just the launch of a new device; it's a calculated strategic move to capture a significant share of the burgeoning non-invasive aesthetics market.
Chief Executive Officer at BENEV, Ethan Min, stated We are thrilled and honored to partner with LaserAway to introduce the XTherma device to their clinics across the country. This partnership reflect shared commitment to innovation, quality, and delivering transformative results to patients.
A recent report by Towards Healthcare highlights that the Therapy devices market is witnessing significant growth, driven by technological advancements like AI integration, a rising prevalence of chronic conditions, and increasing demand for home-based, non-invasive treatment options to improve patient outcomes.